FR05C0045I2 - - Google Patents

Info

Publication number
FR05C0045I2
FR05C0045I2 FR05C0045C FR05C0045C FR05C0045I2 FR 05C0045 I2 FR05C0045 I2 FR 05C0045I2 FR 05C0045 C FR05C0045 C FR 05C0045C FR 05C0045 C FR05C0045 C FR 05C0045C FR 05C0045 I2 FR05C0045 I2 FR 05C0045I2
Authority
FR
France
Prior art keywords
pct
date sep
sec
pub
antiobiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR05C0045C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of FR05C0045I1 publication Critical patent/FR05C0045I1/fr
Application granted granted Critical
Publication of FR05C0045I2 publication Critical patent/FR05C0045I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR05C0045C 1993-03-12 2005-11-17 Active FR05C0045I2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3329193A 1993-03-12 1993-03-12
PCT/US1994/001862 WO1994020505A1 (en) 1993-03-12 1994-03-07 Crystalline ceftiofur free acid

Publications (2)

Publication Number Publication Date
FR05C0045I1 FR05C0045I1 (pt) 2006-01-06
FR05C0045I2 true FR05C0045I2 (pt) 2007-08-03

Family

ID=21869579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0045C Active FR05C0045I2 (pt) 1993-03-12 2005-11-17

Country Status (31)

Country Link
US (1) US5721359A (pt)
EP (1) EP0690864B1 (pt)
JP (1) JP3852946B2 (pt)
KR (1) KR100296810B1 (pt)
CN (1) CN1055090C (pt)
AT (1) ATE202109T1 (pt)
AU (1) AU694419B2 (pt)
BR (1) BR1101034A (pt)
CA (1) CA2155322C (pt)
CZ (1) CZ289332B6 (pt)
DE (2) DE69427469T2 (pt)
DK (1) DK0690864T3 (pt)
ES (1) ES2157254T3 (pt)
FI (1) FI120307B (pt)
FR (1) FR05C0045I2 (pt)
GR (1) GR3036514T3 (pt)
HU (1) HU222244B1 (pt)
IL (1) IL108910A (pt)
LU (1) LU91206I2 (pt)
LV (1) LV12889B (pt)
NL (1) NL300208I2 (pt)
NO (2) NO313199B1 (pt)
NZ (1) NZ263002A (pt)
PL (1) PL184611B1 (pt)
PT (1) PT690864E (pt)
RU (1) RU2136685C1 (pt)
SI (1) SI0690864T1 (pt)
SK (1) SK283674B6 (pt)
TW (1) TW267170B (pt)
WO (1) WO1994020505A1 (pt)
ZA (1) ZA941586B (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
EP1317256B1 (en) * 2000-09-12 2008-10-29 Pharmacia & Upjohn Company LLC Pharmaceutical composition having modified carrier
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
CA2453182A1 (en) * 2001-07-10 2003-01-23 Meredith L. Greene Crystalline thiazine oxazolidinones
EP3168218B1 (en) 2001-08-15 2018-11-14 Pharmacia & Upjohn Company LLC A crystal comprising an l-malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide for use as a medicament
KR20040097187A (ko) † 2002-03-21 2004-11-17 파마시아 앤드 업존 캄파니 동물의 귀로의 주사가능한 항생제의 투여 방법
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) * 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP5230934B2 (ja) * 2003-03-27 2013-07-10 バジリア ファルマスーチカ アーゲー 結晶形態のセファロスポリン
WO2005092889A1 (ja) 2004-03-25 2005-10-06 Astellas Pharma Inc. ソリフェナシンまたはその塩の固形製剤用組成物
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
BRPI0617561A2 (pt) * 2005-10-12 2011-08-23 Orchid Chemicals & Pharm Ltd sal de sódio cristalino antibiótico de cefalosporina
US8470809B2 (en) * 2005-10-12 2013-06-25 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
TW201446748A (zh) 2007-08-22 2014-12-16 Astrazeneca Ab 環丙基醯胺衍生物
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8431562B2 (en) * 2008-08-22 2013-04-30 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
WO2010059717A2 (en) * 2008-11-19 2010-05-27 Merial Limited Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
PE20120003A1 (es) * 2009-01-30 2012-02-12 Glaxosmithkline Llc Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
BR112012020629A2 (pt) 2010-02-18 2018-06-19 Astrazeneca Ab forma cristalina, e, método para a terapia de um distúrbio
CA2789884A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
EP2705044A1 (en) 2011-05-02 2014-03-12 Zoetis Llc Novel cephalosporins useful as antibacterial agents
US8975310B2 (en) 2011-07-20 2015-03-10 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
MX369385B (es) 2011-09-13 2019-11-07 Univ Brigham Young Productos para cicatrizar heridas tisulares.
CA2852989C (en) 2011-09-13 2021-06-29 Brigham Young University Compositions for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
JP6051230B2 (ja) 2011-12-21 2016-12-27 ブリガム ヤング ユニバーシティ 口腔ケア組成物
CN102584855B (zh) * 2012-02-16 2014-06-25 青岛科技大学 一种改进的头孢噻呋的制备方法
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP3225113B1 (en) 2012-05-02 2020-09-02 Brigham Young University Methods for making ceragenin particulate materials
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
CA2897150C (en) 2013-01-07 2021-07-13 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
RU2669800C2 (ru) 2013-03-15 2018-10-16 Брихэм Янг Юниверсити Способы лечения воспаления, аутоиммунных расстройств и боли
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
RU2546675C2 (ru) * 2013-04-11 2015-04-10 Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
KR20230159631A (ko) * 2013-09-05 2023-11-21 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
HUE051693T2 (hu) * 2014-10-21 2021-03-29 Ariad Pharma Inc 5-Klór-N4-[2-(dimetilfoszforil)-fenil]-N2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)-piperidin-1-il] -pirimidin-2,4-diamin kristályos formái
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
KR101753842B1 (ko) * 2015-05-12 2017-07-04 한국화학연구원 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) * 2015-09-18 2019-07-02 瑞普（天津）生物药业有限公司 一种长效头孢噻呋自由酸晶体的制备方法
LT3390358T (lt) * 2016-01-22 2020-11-25 Sandoz Ag Kristalinis eravaciklino bis-hidrochloridas
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) * 2016-05-24 2018-09-13 주식회사 고려비엔피 항생제의 서방형 수의학적 조성물 및 이의 제조방법
MA45588A (fr) 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc Formes solides d'un stimulateur de la gcs
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
TW202233625A (zh) * 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1207933B (de) * 1962-12-26 1965-12-30 American Home Prod Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
CY773A (en) * 1967-09-05 1975-03-01 Bristol Myers Co Antibacterial agents and a process for the preparation thereof
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
JPH0749432B2 (ja) * 1985-08-12 1995-05-31 ジ・アップジョン・カンパニ− セファロスポリンハロゲン化水素酸塩のアルカリ金属塩への変換
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
ES2032543T3 (es) * 1987-02-02 1993-02-16 Eli Lilly And Company Procedimiento mejorado de preparacion de un antibiotico.
DE3869135D1 (de) * 1987-07-29 1992-04-16 Upjohn Co Kontrollierte freisetzung von antibiotika-salzen aus einem implantat.
JP2703964B2 (ja) * 1987-11-10 1998-01-26 ジ・アップジョン・カンパニー セファロスポリン抗生物質類
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes

Also Published As

Publication number Publication date
RU2136685C1 (ru) 1999-09-10
DE122005000055I1 (de) 2006-02-23
PT690864E (pt) 2001-11-30
FI954250A (fi) 1995-09-11
PL310556A1 (en) 1995-12-27
NO2005025I1 (no) 2005-12-05
FI120307B (fi) 2009-09-15
NL300208I1 (nl) 2006-02-01
CA2155322A1 (en) 1994-09-15
CN1055090C (zh) 2000-08-02
SK111495A3 (en) 1995-12-06
CN1119016A (zh) 1996-03-20
BR1101034A (pt) 2002-04-30
EP0690864A1 (en) 1996-01-10
DK0690864T3 (da) 2001-09-17
LV12889B (lv) 2002-12-20
CZ289332B6 (cs) 2002-01-16
ZA941586B (en) 1995-09-07
PL184611B1 (pl) 2002-11-29
JP3852946B2 (ja) 2006-12-06
JPH08507519A (ja) 1996-08-13
ATE202109T1 (de) 2001-06-15
CZ9502290A3 (cs) 2001-08-15
NO953564D0 (no) 1995-09-11
FR05C0045I1 (pt) 2006-01-06
IL108910A (en) 1999-10-28
HU222244B1 (hu) 2003-05-28
WO1994020505A1 (en) 1994-09-15
US5721359A (en) 1998-02-24
DE122005000055I2 (de) 2008-06-05
HUT73781A (en) 1996-09-30
SI0690864T1 (en) 2001-10-31
NZ263002A (en) 1996-12-20
TW267170B (pt) 1996-01-01
KR100296810B1 (ko) 2001-10-24
NO953564L (no) 1995-11-07
ES2157254T3 (es) 2001-08-16
FI954250A0 (fi) 1995-09-11
AU6351094A (en) 1994-09-26
AU694419B2 (en) 1998-07-23
DE69427469D1 (en) 2001-07-19
NL300208I2 (nl) 2006-05-01
SK283674B6 (sk) 2003-11-04
LU91206I2 (fr) 2006-05-30
EP0690864B1 (en) 2001-06-13
NO2005025I2 (no) 2010-11-22
IL108910A0 (en) 1994-06-24
HU9501960D0 (en) 1995-09-28
CA2155322C (en) 2000-02-29
GR3036514T3 (en) 2001-12-31
DE69427469T2 (de) 2001-10-31
NO313199B1 (no) 2002-08-26

Similar Documents

Publication Publication Date Title
FR05C0045I2 (pt)
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
PL312739A1 (en) New derivatives of perhydro isoindole, their production and pharmaceutical compounds containing them
PL310171A1 (en) Novel imidazopyridines
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
HUT71584A (en) Lipopeptide derivatives and pharmaceutical compositions containing them
HUT72594A (en) New prednisolone derivative, process for its production, pharmaceutical composition containing the same
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
GB9126725D0 (en) Process
AU1067295A (en) Substituted aminoalkylaminopyridines
ES8606272A1 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
AU681373B2 (en) Process for preparing C-substituted diethylene triamines
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them